-
Mashup Score: 6AGENT™ Drug-Coated Balloon (DCB) - Boston Scientific - 14 day(s) ago
AGENT expands treatment options for in-stent restenosis (ISR). Designed to deliver a targeted anti-proliferative drug dose without adding extra layers of metal.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0SENTINEL™ Can Protect Patients from Stroke - 18 day(s) ago
Watch a live case and see how the SENTINEL embolic protection device works to capture and remove stroke-causing debris during TAVR.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0SENTINEL Brief Summary - 18 day(s) ago
SENTINEL Brief Summary
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 27FARAPULSE - Pulsed Field Ablation System - 20 day(s) ago
Learn more about pulsed field ablation (PFA) and future ablation technologies such as the FARAPULSE TM Pulsed Field Ablation System. The design goals of FARAPULSE: Mounting clinical data ranging from esophageal safety to PVI durability is available on the emerging new therapy of pulsed field ablation and the FARAPULSE PFA System. See clinical data 0% AE Fistulas, Phrenic Nerve Damage, PV Stenosis 1 Pulsed Field Ablation (PFA) uses a non-thermal energy source that spares collateral tissues while preferentia
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 1Dual-stage Algorithms - LUX-Dx II+ ICM - Boston Scientific - 22 day(s) ago
The LUX-Dx II+™ Insertable Cardiac Monitor System’s dual-stage algorithms automatically detect and verify data so you can evaluate actionable alerts.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 8Clinical evidence - POLARx Cryoablation System - 22 day(s) ago
Numerous studies have demonstrated the safety and efficacy of the POLARx™ Cryoablation System in the treatment of paroxysmal atrial fibrillation. It has been studied and is in use in multiple countries across the globe.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4
As the world’s only subcutaneous implantable cardioverter defibrillator, the EMBLEM S-ICD System protects patients from sudden cardiac arrest (SCA).
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7
The utility of atrioventricular (AV) optimization (AVO) algorithms remains in question. A substudy of the SMART-AV trial found that patients with prolonged interventricular delays ≥70 ms were more likely to benefit from cardiac resynchronization therapy (CRT) with AVO. The SMART-CRT trial evaluated AVO on the basis of these results, but the study was underpowered.
Source: www.heartrhythmjournal.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4Paid Program: Rethinking Care for Atrial Fibrillation - 27 day(s) ago
How a pioneering medical device is poised to transform treatment for people with atrial fibrillation.
Source: partners.wsj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Paid Program: Rethinking Care for Atrial Fibrillation - 27 day(s) ago
How a pioneering medical device is poised to transform treatment for people with atrial fibrillation.
Source: partners.wsj.comCategories: General Medicine News, PayerTweet
@ESHLOF @ziadalinyc @DrAllenJ @StFrancis_LI @rwyeh @EricSecemskyMD @hectortamezmd @BIDMChealth We appreciate all the members of our community who help advance the treatment of ISR. The AGENT™ DCB is the first and only coronary drug-coated balloon in the U.S. and introduces a new treatment option for patients with in-stent restenosis. Learn more: https://t.co/KsLfnOuYYx